Aug 13, 2026 05:12PM
Aug 13, 2026 05:12PM
Jul 13, 2026 06:59AM
Jul 13, 2026 06:59AM
Jun 1, 2026 06:59AM
Jun 1, 2026 06:59AM
Feb 17, 2026 05:31PM Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight
Feb 17, 2026 07:00AM
Feb 17, 2026 06:59AM
Dec 11, 2025 06:59AM
Dec 11, 2025 06:59AM
Oct 27, 2025 06:59AM
Oct 27, 2025 06:59AM
Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
Aug 4, 2025 04:16PM
Aug 4, 2025 04:16PM
Jul 21, 2025 07:00AM
Jul 21, 2025 06:59AM
Apr 8, 2025 03:39PM
Apr 8, 2025 03:36PM
Mar 7, 2025 06:59AM Bristol-Myers Squibb (BMY) Receives European Commission Approval for Opdivo plus Yervoy for the First-Line Treatment of Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma
Mar 7, 2025 06:59AM
Feb 24, 2025 06:59AM
Feb 24, 2025 06:59AM
Feb 6, 2025 06:59AM
Jan 31, 2025 06:59AM
Jan 31, 2025 06:59AM
Dec 11, 2024 09:44AM Truist: 'Potential Impact of Trump's Nominees on Biopharma'
Oct 31, 2024 06:59AM
Sep 27, 2024 08:05AM
Sep 27, 2024 06:07AM
Sep 23, 2024 07:28AM
Aug 28, 2024 02:01AM
Aug 21, 2024 07:00AM
Aug 21, 2024 06:59AM Bristol Myers Squibb Receives U.S. Food and Drug Administration sBLA Acceptance for First-Line Treatment of Unresectable Hepatocellular Carcinoma
Jul 26, 2024 06:59AM
Jul 23, 2024 06:35AM
Jun 17, 2024 09:45AM
May 21, 2024 06:59AM
May 21, 2024 06:59AM
May 6, 2024 06:59AM
May 6, 2024 06:59AM U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
Apr 25, 2024 06:59AM
Apr 25, 2024 05:22AM
Apr 8, 2024 11:31AM
Apr 8, 2024 11:30AM
Apr 1, 2024 07:31AM
Apr 1, 2024 07:30AM
Mar 28, 2024 04:07PM Bristol-Myers Squibb (BMY) Announces KRYSTAL-12 Trial of KRAZATI Met Primary Endpoint
Mar 28, 2024 04:05PM

15,747 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All